A bibliometric visualization of resistance to lung cancer immunotherapy: a decade of research progress (2014–2024)

This study offers a thorough overview of the most important research topics and emerging trends related to drug resistance and lung cancer immunotherapy. By integrating current knowledge, it enables researchers to swiftly identify pivotal research directions, thereby promoting in-depth development and innovation within the field and supporting the progression of clinical practice. For clinicians, this bibliometric insight provides a more scientific and precise basis for formulating treatment strategies, ultimately assisting lung cancer patients in deriving benefits from immunotherapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-11-10
DOI
https://doi.org/10.3389/fonc.2025.1656967
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A bibliometric visualization of resistance to lung cancer immunotherapy: a decade of research progress (2014–2024)

Jianchun Wu, Xiangyu Ren, Yuli Wang, Xiaobin Li et al.
Frontiers in Oncology
Cancer Immunotherapy and Biomarkers
article

A bibliometric visualization of resistance to lung cancer immunotherapy: a decade of research progress (2014–2024)

Jianchun Wu, Xiangyu Ren, Yuli Wang, Xiaobin Li, Lanlan Yang, Zhuo Yang, Yajing Cui
article en

Abstract

This study offers a thorough overview of the most important research topics and emerging trends related to drug resistance and lung cancer immunotherapy. By integrating current knowledge, it enables researchers to swiftly identify pivotal research directions, thereby promoting in-depth development and innovation within the field and supporting the progression of clinical practice. For clinicians, this bibliometric insight provides a more scientific and precise basis for formulating treatment strategies, ultimately assisting lung cancer patients in deriving benefits from immunotherapy.

Frontiers in OncologyVol. 15
Shanghai University of Traditional Chinese Medicine (CN)
Openalex Percentile: Top 54%
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A bibliometric visualization of resistance to lung cancer immunotherapy: a decade of research progress (2014–2024) — Jianchun Wu, Xiangyu Ren, et al. · Frontiers in Oncology (2025) | TGRS Research Map | TGRS